Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117584 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus
A Phase 2 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 343
- Enrollment target
NCT01117584 is a Phase 2 study that has completed, run by Astellas Pharma. The registered enrollment target is 343 participants.
The verdict
NCT01117584, a Phase 2 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 343 participants
- Enrollment target
Study Summary
Evaluate the efficacy, safety and tolerability of a 12-week treatment of 4 doses of ASP1941 compared to placebo in combination with metformin in adult patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin alone.
Interventions
- DRUG Placebo
- DRUG Metformin
- DRUG ipragliflozin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2010-04-06 |
| Est. Completion | 2011-04-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117584
The ClinicalTrials.gov registry entry for NCT01117584 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 343 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01117584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117584 about?
NCT01117584 is a clinical study titled "A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus". Evaluate the efficacy, safety and tolerability of a 12-week treatment of 4 doses of ASP1941 compared to placebo in combination with metformin in adult patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin alone.
What is the current status of trial NCT01117584?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 343 participants. The study started on 2010-04-06. Estimated completion is 2011-04-01.
What interventions are being tested in trial NCT01117584?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), ipragliflozin (DRUG).
Who is sponsoring clinical trial NCT01117584?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.